Comparing one-person and two-person techniques in single-balloon enteroscopy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study compares the effectiveness of single-operator versus double-operator techniques in single-balloon enteroscopy for diagnosing and treating small bowel diseases. It aims to evaluate whether a single operator can provide better observation and treatment of lesions, reduce examination time, and minimize postoperative discomfort compared to a two-person approach. The study will involve patients suspected of having small bowel disease and will assess the depth of insertion and overall examination quality. By focusing on a more efficient method, the study seeks to optimize resource use in endoscopy rooms.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* age greater than eighteen years;
* suspected small bowel disease with planned enteroscopy

Exclusion Criteria:

* patients with a history of small bowel surgery;
* patients who fail to perform bowel preparation as required;
* patients with existing esophageal varices at high risk of bleeding;
* patients not requiring a deep small-bowel examination, such as those with lesions clearly localized to the proximal jejunum, or terminal ileum;
* patients who are in extremely poor physical condition and are not suitable for general anesthesia, as defined by an ASA score greater than 3;
* pregnant or lactating women;
* patients unable to provide written informed consent.

Where it's running

• The First Hospital of Lanzhou University
  Lanzhou, Gansu, China Recruiting
• The Second Hospital & Clinical Medical School, Lanzhou University
  Lanzhou, Gansu, China Recruiting
• The Fifth Affiliated Hospital of Zunyi Medical University
  Zhuhai, Guangdong, China Recruiting
• The Second Affiliated Hospital of Xi'an Jiaotong University
  Xi'an, Shannxi, China Recruiting
• Xi'an Honghui Hospital
  Xi'an, Shannxi, China Recruiting
• Xijing Hospital of Digestive Diseases
  Xi'an, Shannxi, China Recruiting

Study contacts

• Study coordinator: Shuhui Liang
• Email: liangsh@fmmu.edu.cn
• Phone: 86-20-84771536

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Dual-drug therapy with linlarase glutarate and amoxicillin vs bismuth quadruple therapy for first-line Helicobacter pylori eradication

  This trial tests whether a dual-drug regimen of linlarase glutarate capsules plus amoxicillin can match the effectiveness of a standard bismuth-containing quadruple therapy for first-line Helicobacter pylori eradication.

  Recruiting at 24 sites Phase 4 Xijing Hospital of Digestive Diseases · Zhengzhou, Henan and 23 other locations · NCT07897994

• Active video education by disease subtype to improve bowel prep before colonoscopy

  We’re testing whether adding subtype-specific video education to standard prep improves bowel cleanliness in adults with IBD undergoing colonoscopy.

  Recruiting at 12 sites Xijing Hospital of Digestive Diseases · Beijing, BeijingBeijing and 11 other locations · NCT07582731

• Upadacitinib versus infliximab for second-line treatment of acute severe ulcerative colitis

  This trial will see if upadacitinib or infliximab works better to induce remission in adults with acute severe ulcerative colitis who need second-line therapy.

  Recruiting at 4 sites Phase 4 Xijing Hospital of Digestive Diseases · Ankang, Shaanxi and 3 other locations · NCT07550673

• Upadacitinib versus corticosteroids for first-line treatment of acute severe ulcerative colitis

  This test will see if upadacitinib works as well as corticosteroids to induce remission in adults with acute severe ulcerative colitis.

  Recruiting at 4 sites Phase 4 Xijing Hospital of Digestive Diseases · Ankang, Shaanxi and 3 other locations · NCT07546097

• Microplastic exposure and progression of stomach precancerous changes

  This project will test if adults with higher microplastic exposure are more likely to have precancerous stomach changes or gastric cancer.

  Recruiting Xijing Hospital of Digestive Diseases · Xi'an, Shaanxi · NCT07542652

• Impact of full-time RDI on major adverse events and procedure time during endoscopic submucosal dissection for early gastric cancer or gastric adenoma

  This study tests whether using Red Dichromatic Imaging (RDI) during endoscopic submucosal dissection (ESD) can reduce major adverse events and shorten procedure time for adults with early gastric cancer or gastric adenoma.

  Recruiting Xijing Hospital of Digestive Diseases · Xi'an, Shaanxi · NCT07401303

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.